Matches in Wikidata for { <http://www.wikidata.org/entity/Q93264563> ?p ?o ?g. }
Showing items 1 to 49 of
49
with 100 items per page.
- Q93264563 description "artículu científicu espublizáu n'abril de 2020" @default.
- Q93264563 description "scientific article published on 28 April 2020" @default.
- Q93264563 description "wetenschappelijk artikel" @default.
- Q93264563 description "наукова стаття, опублікована 28 квітня 2020" @default.
- Q93264563 name "Safety and effectiveness of adalimumab in Japanese patients with juvenile idiopathic arthritis: Results from a real-world postmarketing study" @default.
- Q93264563 name "Safety and effectiveness of adalimumab in Japanese patients with juvenile idiopathic arthritis: Results from a real-world postmarketing study" @default.
- Q93264563 type Item @default.
- Q93264563 label "Safety and effectiveness of adalimumab in Japanese patients with juvenile idiopathic arthritis: Results from a real-world postmarketing study" @default.
- Q93264563 label "Safety and effectiveness of adalimumab in Japanese patients with juvenile idiopathic arthritis: Results from a real-world postmarketing study" @default.
- Q93264563 prefLabel "Safety and effectiveness of adalimumab in Japanese patients with juvenile idiopathic arthritis: Results from a real-world postmarketing study" @default.
- Q93264563 prefLabel "Safety and effectiveness of adalimumab in Japanese patients with juvenile idiopathic arthritis: Results from a real-world postmarketing study" @default.
- Q93264563 P1433 Q93264563-D12157C3-2464-4B13-8A2A-FD8A9592838A @default.
- Q93264563 P1476 Q93264563-27421224-9377-4F9D-8DED-6AB6F3F82B2C @default.
- Q93264563 P2093 Q93264563-24B25321-22A3-44F3-87E2-B24F4B40EE09 @default.
- Q93264563 P2093 Q93264563-4021B38B-228B-4980-A2E3-AC7AAD638156 @default.
- Q93264563 P2093 Q93264563-49EFA9FC-43E8-416A-B885-2006F057DA61 @default.
- Q93264563 P2093 Q93264563-89469F15-1C06-4BEA-A4D5-2CD698DE8F80 @default.
- Q93264563 P2093 Q93264563-A326232C-DFFB-4FA1-AE7E-07589276FA08 @default.
- Q93264563 P2093 Q93264563-A6A13E58-55EA-4E2C-A96E-A744C958F14C @default.
- Q93264563 P2093 Q93264563-B0E32E58-82D3-40FF-B449-858BB69A67C2 @default.
- Q93264563 P2093 Q93264563-B0E5C2B3-3036-4B9F-ABC5-578F533F4FCC @default.
- Q93264563 P2093 Q93264563-FA80253F-0795-44D5-BFF7-9A833B52F6FB @default.
- Q93264563 P304 Q93264563-9047DDC9-0D6B-4AEA-ACD7-2C0807AB1D44 @default.
- Q93264563 P31 Q93264563-F12721CA-ED97-48B1-8835-36FED41113A0 @default.
- Q93264563 P356 Q93264563-E9AE002C-B158-41D1-B5F3-608E1C887483 @default.
- Q93264563 P577 Q93264563-9EEFCE42-E594-4A44-9E84-1C9101C8AEE1 @default.
- Q93264563 P698 Q93264563-38806EC2-B949-4F51-9046-9FB60C955CBC @default.
- Q93264563 P921 Q93264563-1AEA39AD-BBAA-4685-B299-BB8DC36E9FC0 @default.
- Q93264563 P921 Q93264563-E7BF0E6F-0C4D-43F1-9848-FFCBC9845D0A @default.
- Q93264563 P356 14397595.2020.1761075 @default.
- Q93264563 P698 32340508 @default.
- Q93264563 P1433 Q15752709 @default.
- Q93264563 P1476 "Safety and effectiveness of adalimumab in Japanese patients with juvenile idiopathic arthritis: Results from a real-world postmarketing study" @default.
- Q93264563 P2093 "Ayumi Ito" @default.
- Q93264563 P2093 "Ichiro Kobayashi" @default.
- Q93264563 P2093 "Naoko Matsubara" @default.
- Q93264563 P2093 "Naomi Iwata" @default.
- Q93264563 P2093 "Naomi Sunaga" @default.
- Q93264563 P2093 "Shumpei Yokota" @default.
- Q93264563 P2093 "Syuji Takei" @default.
- Q93264563 P2093 "Toru Igarashi" @default.
- Q93264563 P2093 "Yoko Yoshinaga" @default.
- Q93264563 P304 "1-25" @default.
- Q93264563 P31 Q13442814 @default.
- Q93264563 P356 "10.1080/14397595.2020.1761075" @default.
- Q93264563 P577 "2020-04-28T00:00:00Z" @default.
- Q93264563 P698 "32340508" @default.
- Q93264563 P921 Q348260 @default.
- Q93264563 P921 Q861224 @default.